Clostridioides difficile infection is a leading cause of healthcare-associated infections with
significant morbidity and mortality. For the past decade, the bulk of infection prevention and …

Clostridioides difficile is the most common cause of healthcare-associated diarrhea. Disease
complications as well as recurrent infections contribute significantly to morbidity and …

Importance An understanding of the incidence and outcomes ofClostridium difficileinfection
(CDI) in the United States can inform investments in prevention and treatment interventions …

Background: Microbiota-based treatments reduce the incidence of recurrent Clostridioides
difficile infections (rCDIs), but prospectively collected safety data needed to broaden patient …

Background & Aims Fecal microbiota transplantation (FMT) is commonly used to treat
Clostridium difficile infection (CDI). CDI is an increasing cause of diarrheal illness in …

Objectives Clostridioides difficile infection (CDI) is a common healthcare-associated
infection and leading cause of gastroenteritis-related mortality worldwide. However, data on …

Abstract Background In 2018, the Infectious Diseases Society of America (IDSA) published
guidelines for diagnosis and treatment of Clostridioides (formerly Clostridium) difficile …

The microbiota inhabiting the intestinal tract provide several critical functions to its host.
Microorganisms found at the mucosal layer form organized three-dimensional structures …

Abstract Background Both the American College of Gastroenterology and the Infectious
Diseases Society of America (IDSA)/Society for Healthcare Epidemiology of America 2021 …

Introduction Clostridioides difficile infection (CDI) is a major public health threat. Up to 40%
of patients with CDI experience recurrent CDI (rCDI), which is associated with increased …